Table 2

Characteristics of all patients with and without BSI

Variable

BSI

N = 17

Non BSI

N = 85

p value


Gender

Male

3 (17.6%)

50 (57.7%)

0.004

Female

14 (82.3%)

35 (41.2%)


Age

49.50 ± 14.62

54.01 ± 1.22

0.293


Length of stay

41.56 ± 20.05

17.81 ± 13.27

< 0.001


Duration of neutropenia

21.06 ± 8.33

5,07 ± 8,32

< 0.001


Karnofsky score

77.50 ± 16.93

81.40 ± 11.99

0.390


IPS score

11.06 ± 5.10

6.59 ± 6.41

0.010


Apache score

12.19 ± 4.60

12.38 ± 4.38

0.876


Neutropenia

16 (94.1%)

31 (36.5%)

< 0.001

Underlying disease

Infection at admission

2 (11.7%)

23 (27.1%)

0.187

Diabetes

1 (5.9%)

6 (7.1%)

0.698


Underling malignancy

Acute myeloid leukemia

13 (76.5%)

22 (25.9%)

< 0.001

Acute lymphocytic leukemia

4 (23.5%)

12 (14.1%)

0.221


Exposure to antibiotics

15 (88.2%)

61 (77.7%)

0.045


Exposure to chemotherapy

13 (76.5%)

44 (51.7%)

0.023


Corticosteroid therapy

3 (17.6%)

37 (43.5%)

0.057


Surgery procedure

3 (17.6%)

3 (3.5%)

0.048


Bronchoscopy

1 (5.9%)

3 (3.5%)

0.500


Gastroscopy

1 (5.9%)

6 (7.1%)

0.698


Parenteral nutrition

1 (5.9%)

1 (1.2%)

0.290


Bladder catheter

2 (11.7%)

7 (8.2%)

0.429


CVC

2 (11.7%)

2 (2.3%)

0.115


Hickman catheter

6 (35.3%)

11 (12.9%)

0.025


Peripheral venous catheter

12 (70.60%)

77 (90.6%)

0.119


Death

1 (5.9%)

7 (8.2%)

0.634


Apostolopoulou et al. BMC Infectious Diseases 2010 10:135   doi:10.1186/1471-2334-10-135

Open Data